Literature DB >> 8313896

PI 3-kinase: structural and functional analysis of intersubunit interactions.

R Dhand1, K Hara, I Hiles, B Bax, I Gout, G Panayotou, M J Fry, K Yonezawa, M Kasuga, M D Waterfield.   

Abstract

Phosphatidylinositol (PI) 3-kinase has an 85 kDa subunit (p85 alpha) which mediates its association with activated protein tyrosine kinase receptors through SH2 domains, and an 110 kDa subunit (p110) which has intrinsic catalytic activity. Here p85 alpha and a related protein p85 beta are shown to form stable complexes with recombinant p110 in vivo and in vitro. Using a panel of glutathione S-transferase (GST) fusion proteins of the inter-SH2 region of p85, 104 amino acids were found to bind directly the p110 protein, while deletion mutants within this region further defined the binding site to a sequence of 35 amino acids. Transient expression of the mutant p85 alpha protein in mouse L cells showed it was unable to bind PI 3-kinase activity in vivo. Mapping of the complementary site of interaction on the p110 protein defined 88 amino acids in the N-terminal region of p110 which mediate the binding of this subunit to either the p85 alpha or the p85 beta proteins. The inter-SH2 region of p85 is predicted to be an independently folded module of a coiled-coil of two long anti-parallel alpha-helices. The predicted structure of p85 suggests a basis for the intersubunit interaction and the relevance of this interaction with respect to the regulation of the PI 3-kinase complex is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8313896      PMCID: PMC394840          DOI: 10.1002/j.1460-2075.1994.tb06289.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit.

Authors:  I D Hiles; M Otsu; S Volinia; M J Fry; I Gout; R Dhand; G Panayotou; F Ruiz-Larrea; A Thompson; N F Totty
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  Chromosomal localization of human p85 alpha, a subunit of phosphatidylinositol 3-kinase, and its homologue p85 beta.

Authors:  S Volinia; P Patracchini; M Otsu; I Hiles; I Gout; E Calzolari; F Bernardi; L Rooke; M D Waterfield
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

3.  Structural features in the heptad substructure and longer range repeats of two-stranded alpha-fibrous proteins.

Authors:  J F Conway; D A Parry
Journal:  Int J Biol Macromol       Date:  1990-10       Impact factor: 6.953

4.  Tropomyosin coiled-coil interactions: evidence for an unstaggered structure.

Authors:  A D McLachlan; M Stewart
Journal:  J Mol Biol       Date:  1975-10-25       Impact factor: 5.469

5.  Characterization of the bovine brain cytosolic phosphatidylinositol 3-kinase complex.

Authors:  F Ruiz-Larrea; P Vicendo; P Yaish; P End; G Panayotou; M J Fry; S J Morgan; A Thompson; P J Parker; M D Waterfield
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

6.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

7.  Purification and characterization of bovine brain type I phosphatidylinositol kinase.

Authors:  S J Morgan; A D Smith; P J Parker
Journal:  Eur J Biochem       Date:  1990-08-17

8.  Expression and characterization of the p85 subunit of the phosphatidylinositol 3-kinase complex and a related p85 beta protein by using the baculovirus expression system.

Authors:  I Gout; R Dhand; G Panayotou; M J Fry; I Hiles; M Otsu; M D Waterfield
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

9.  Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression.

Authors:  J Kunz; R Henriquez; U Schneider; M Deuter-Reinhard; N R Movva; M N Hall
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

10.  Phosphoinositide-binding peptides derived from the sequences of gelsolin and villin.

Authors:  P A Janmey; J Lamb; P G Allen; P T Matsudaira
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

View more
  93 in total

1.  Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways.

Authors:  J Celli; M Olivier; B B Finlay
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  Alternative modes of binding of proteins with tandem SH2 domains.

Authors:  R O'Brien; P Rugman; D Renzoni; M Layton; R Handa; K Hilyard; M D Waterfield; P C Driscoll; J E Ladbury
Journal:  Protein Sci       Date:  2000-03       Impact factor: 6.725

3.  Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo.

Authors:  B Vanhaesebroeck; K Higashi; C Raven; M Welham; S Anderson; P Brennan; S G Ward; M D Waterfield
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

4.  Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein.

Authors:  I Gout; G Middleton; J Adu; N N Ninkina; L B Drobot; V Filonenko; G Matsuka; A M Davies; M Waterfield; V L Buchman
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

5.  SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation.

Authors:  S Poser; S Impey; K Trinh; Z Xia; D R Storm
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

6.  The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling.

Authors:  Zheng Fu; Eliah Aronoff-Spencer; Jonathan M Backer; Gary J Gerfen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

7.  The conserved phosphoinositide 3-kinase pathway determines heart size in mice.

Authors:  T Shioi; P M Kang; P S Douglas; J Hampe; C M Yballe; J Lawitts; L C Cantley; S Izumo
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

8.  Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo.

Authors:  Lazaros C Foukas; Caroline A Beeton; Jorgen Jensen; Wayne A Phillips; Peter R Shepherd
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  Mice Carrying a Dominant-Negative Human PI3K Mutation Are Protected From Obesity and Hepatic Steatosis but Not Diabetes.

Authors:  Marie H Solheim; Jonathon N Winnay; Thiago M Batista; Anders Molven; Pål R Njølstad; C Ronald Kahn
Journal:  Diabetes       Date:  2018-05-03       Impact factor: 9.461

10.  Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells.

Authors:  H Sheng; J Shao; C M Townsend; B M Evers
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.